je.st
news
Vertex wins big with approval of new cystic fibrosis drug
2015-07-02 19:21:58| Biotech - Topix.net
The Food and Drug Administration has approved a potential blockbuster drug by Boston-based Vertex Pharmaceuticals to treat cystic fibrosis that is expected to make the company profitable within three years. The drug, called Orkambi, is a combination of the company's existing drug, Kalydeco, with a new drug which makes it usable by about four times as many patients with the disease.
Tags: big
drug
approval
wins
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||
|
|||